Erlotinib
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Teva Pharmaceuticals USA, Inc.
Erlotinib hydrochloride
Listed by Armas Pharmaceuticals Inc.
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 72485-218 |
| FDA application | ANDA211960 |
| RxNorm concept | 603203 |
| Package sizes listed | 1 |
| Marketed since | November 2019 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Teva Pharmaceuticals USA, Inc.
Aurobindo Pharma Limited
Sun Pharmaceutical Industries, Inc.
Zydus Lifesciences Limited
Teva Pharmaceuticals USA, Inc.
Camber Pharmaceuticals, Inc.
Zydus Pharmaceuticals USA Inc.
Camber Pharmaceuticals, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.